Currently, there are 510.93M common shares owned by the public and among those 508.69M shares have been available to trade.
The company’s stock has a 5-day price change of -0.61% and -9.21% over the past three months. BAX shares are trading -4.66% year to date (YTD), with the 12-month market performance down to -31.07% lower. It has a 12-month low price of $26.25 and touched a high of $41.18 over the same period. BAX has an average intraday trading volume of 5.02 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.69%, -14.95%, and -18.57% respectively.
Institutional ownership of Baxter International Inc (NYSE: BAX) shares accounts for 96.13% of the company’s 510.93M shares outstanding.
It has a market capitalization of $14.26B and a beta (3y monthly) value of 0.67. The earnings-per-share (ttm) stands at -$1.27. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.67% over the week and 4.46% over the month.
Earnings per share for the fiscal year are expected to increase by 31.72%, and 9.63% over the next financial year.
Looking at the support for the BAX, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on February 26, 2025, with the firm’s price target at $42. Barclays was of a view on February 20, 2025 that the stock is Overweight, while Morgan Stanley gave the stock Underweight rating on July 15, 2024, issuing a price target of $39- $30. Goldman on their part issued Neutral rating on May 30, 2024.
